Type of pathology | Variation | Univariate logistic regression | Multivariate logistic regression | ||
---|---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | ||
Precancerous conditions | Age ≤ 40 years | Reference | – | Reference | – |
Age between 41 and 50 years | 10.77 (4.59–25.26) | 0.001 | 10.78 (4.54–25.59) | 0.001 | |
Age between 51 and 60 years | 11.35 (4.84–26.57) | 0.001 | 9.88 (4.18–23.35) | 0.001 | |
Age ≥ 61 years | 19.01 (8.24–43.86) | 0.001 | 18.53 (7.94–43.26) | 0.001 | |
NSAID consumption | 0.34 (0.20–0.58) | 0.001 | 0.34 (0.19–0.60) | 0.001 | |
H. pylori infection | 4.33 (2.05–9.16) | 0.001 | 4.01 (1.83–8.78) | 0.001 | |
Abnormal gastric biopsy | Age between 41 and 50 years | 2.55 (1.39–4.67) | 0.002 | 2.32 (1.22–4.39) | 0.01 |
Age between 51 and 60 years | 2.52 (1.38–4.63) | 0.003 | 2.16 (1.14–4.08) | 0.01 | |
Age ≥ 61 years | 3.49 (1.79–6.81) | 0.001 | 3.28 (1.63–6.60) | 0.001 | |
H. pylori infection | 6.29 (3.94–10.01) | 0.001 | 5.92 (3.67–9.55) | 0.001 | |
Atrophy | Age between 41 and 50 years | 12.47 (2.76–56.25) | 0.001 | 11.96 (2.64–52.20) | 0.001 |
Age between 51 and 60 years | 23.19 (5.35–100.56) | 0.001 | 20.19 (4.64–87.90) | 0.001 | |
Age ≥ 61 years | 45.82 (10.80–194.30) | 0.001 | 43.29 (10.16–184.33) | 0.001 | |
NSAID consumption | 0.37 (0.19–0.73) | 0.004 | 0.40 (0.20–0.82) | 0.012 | |
H. pylori infection | 3.1 (1.31–7.35) | 0.01 | 2.72 (1.10–6.71) | 0.029 | |
Metaplasia | Age between 41 and 50 years | 7.6 (2.76–20.92) | 0.001 | 7.31 (2.63–20.29) | 0.001 |
Age between 51 and 60 years | 10.18 (3.77–27.47) | 0.001 | 8.75 (3.22–23.79) | 0.001 | |
Age ≥ 61 years | 21.00 (8.01–55.00) | 0.001 | 20.00 (7.57–52.84) | 0.001 | |
NSAID consumption | 0.35 (0.19–0.66) | 0.001 | 0.37 (0.19–0.71) | 0.003 | |
H. pylori infection | 3.94 (1.67–9.27) | 0.002 | 3.58 (1.47–8.72) | 0.005 | |
Dysplasia | Age between 41 and 50 years | 15.77 (3.56–69.87) | 0.001 | 16.29 (3.66–72.38) | 0.001 |
Age between 51 and 60 years | 8.40 (1.78–39.57) | 0.013 | 7.65 (1.62–36.11) | 0.013 | |
Age ≥ 61 years | 19.45 (4.44–85.11) | 0.001 | 18.64 (4.25–81.79) | 0.001 | |
NSAID consumption | 0.33 (0.13–0.80) | 0.014 | 0.33 (0.13–0.82) | 0.017 |